title: Effect of eicosapentaenoic acid in patients with refractory myelodysplastic syndrome.
authors.forename: Takahiro
authors.initials: T
authors.lastname: Okamoto
authors.forename: Masaya
authors.initials: M
authors.lastname: Okada
authors.forename: Takeshi
authors.initials: T
authors.lastname: Wakae
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Takatsuka
authors.forename: Eizo
authors.initials: E
authors.lastname: Kakishita
mesh_terms: D000368:Aged; D001095:Arachidonic Acids / Q000627:therapeutic use*; D001803:Blood Transfusion; D001853:Bone Marrow / Q000473:pathology; D016572:Cyclosporine / Q000627:therapeutic use; D006490:Hemostatics / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000175:diagnosis / Q000628:therapy*; D010976:Platelet Count; D016896:Treatment Outcome; D024482:Vitamin K 2 / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D001095:Arachidonic Acids; D006490:Hemostatics; D024482:Vitamin K 2; C030814:menatetrenone; D016572:Cyclosporine